rs1553192091
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3PP5_Moderate
The ENST00000295598.10(ATP1A1):c.1798C>A(p.Pro600Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P600A) has been classified as Pathogenic.
Frequency
Consequence
ENST00000295598.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1A1 | NM_000701.8 | c.1798C>A | p.Pro600Thr | missense_variant | 13/23 | ENST00000295598.10 | NP_000692.2 | |
ATP1A1-AS1 | NR_027646.1 | n.401-2221G>T | intron_variant, non_coding_transcript_variant | |||||
ATP1A1 | NM_001160233.2 | c.1798C>A | p.Pro600Thr | missense_variant | 13/23 | NP_001153705.1 | ||
ATP1A1 | NM_001160234.2 | c.1705C>A | p.Pro569Thr | missense_variant | 13/23 | NP_001153706.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1A1 | ENST00000295598.10 | c.1798C>A | p.Pro600Thr | missense_variant | 13/23 | 1 | NM_000701.8 | ENSP00000295598 | P4 | |
ATP1A1-AS1 | ENST00000675607.1 | n.385+5649G>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-marie-tooth disease, axonal, type 2DD Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 28, 2018 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 06, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro600 amino acid residue in ATP1A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29499166). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects ATP1A1 function (PMID: 29499166). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP1A1 protein function. ClinVar contains an entry for this variant (Variation ID: 545679). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 29499166). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 600 of the ATP1A1 protein (p.Pro600Thr). - |
Charcot-Marie-Tooth disease type 2A2 Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium Ii, University Of Miami | Oct 07, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at